Aspira Pathlab & Diagnostics Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 26.04 million compared to INR 29.67 million a year ago. Revenue was INR 27.04 million compared to INR 30.32 million a year ago.

Net loss was INR 7.16 million compared to INR 2.85 million a year ago. Basic loss per share from continuing operations was INR 0.7 compared to INR 0.28 a year ago. Diluted loss per share from continuing operations was INR 0.7 compared to INR 0.28 a year ago.